Sean Bohen, Olema Oncology CEO

Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

Ole­ma On­col­o­gy, the Bay Area biotech run by for­mer As­traZeneca ex­ec­u­tive Sean Bo­hen, raised $130 mil­lion from a pri­vate place­ment and a cred­it fa­cil­i­ty of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.